logo

For the Inventor, By the Inventor

Brookline, MA, United States of America

Laurence G Rahme

This inventor holds 10 USPTO granted patents and 9 published patent applications and 4 EPO patents. Top assignees: The General Hospital Corporation, Aptuit (Verona) Srl, an Evotec Company, East Carolina University. Active years: 2002-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Laurence G Rahme. Retrieved from https://idiyas.com/inventor/laurence-g-rahme

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 90.0

 

Average Co-Inventor Count = 5.7

ph-index = 3

Forward Citations = 23(Granted Patents)


Location History:

  • Jamaica Plain, MA (US) (2014 - 2016)
  • Brookline, MA (US) (2002 - 2023)

Company Filing History:

goldMedal10 out of 3,073 
 
The General Hospital Corporation
 patents
silverMedal1 out of 1 
 
Aptuit (Verona) Srl, an Evotec Company
 patent
bronzeMedal1 out of 125 
 
East Carolina University
 patents
4. 1 out of 128 
 
Institut National De La Recherche Scientifique
 patents
5. 1 out of 621 
 
Memorial Sloan Kettering Cancer Center
 patents
6. 1 out of 8 
 
The Netherlands Cancer Institute
 patents
where one patent can have more than one assignee

Years Active: 2002-2023

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 11731946 - Broad spectrum antivirulence, anti-persistence compounds (2023-08-22),
2. 10874686 - Anthranilyl-adenosinemonosulfamate analogs and uses thereof (2020-12-29),
3. 10550431 - Methods and assays relating to the treatment of infection (2020-02-04),
4. 9457057 - Methods for the prevention and treatment of burn injuries and secondary complications (2016-10-04),
5. 8906602 - Methods for identifying candidate compounds for treating, reducing, or preventing pathogenic infections (2014-12-09),
6. 8877940 - Antibiotic tolerance inhibitors (2014-11-04),
7. 7166270 - Methods of screening compounds useful for prevention of infection or pathogenicity (2007-01-23),
8. 6905670 - Methods of screening compounds useful for prevention of infection or pathogenicity (2005-06-14),
9. 6461854 - Methods of screening compounds useful for prevention of infection or pathogenicity (2002-10-08),
10. 6355411 - Virulence-associated nucleic acid sequences and uses thereof (2002-03-12),

Title: The Innovative Contributions of Laurence G Rahme

Introduction

Laurence G Rahme is a prominent inventor based in Brookline, MA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, he has made remarkable strides in developing compounds that address various bacterial infections.

Latest Patents

Among his latest patents, Rahme has developed broad-spectrum antivirulence and anti-persistence compounds. The present application provides malonamide compounds and derivatives, such as N-aryl malonamides, acetamides, and oxalamides, which are useful for treating acute, chronic, and relapsing infections. Additionally, he has worked on anthranilyl-adenosinemonosulfamate analogs, providing compounds and pharmaceutical compositions for treating infectious diseases, particularly bacterial infections.

Career Highlights

Rahme has had a distinguished career, working with notable organizations such as The General Hospital Corporation and Institut National De La Recherche Scientifique. His work has significantly impacted the development of new therapeutic strategies for combating bacterial infections.

Collaborations

Some of his notable coworkers include Frederick M Ausubel and Man-Wah Tan, who have collaborated with him on various research projects.

Conclusion

Laurence G Rahme's innovative work in the pharmaceutical field continues to pave the way for new treatments for bacterial infections. His contributions are invaluable to the scientific community and the advancement of medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…